Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
Yahoo

The PSA test for prostate cancer – everything you need to know

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

PSA Increasing Card Grading Prices and Turnaround Times

In an effort to slow down submissions, PSA has increased the price and turnaround times of some services levels in their system.
Yahoo

What Your PSA Test Says About Your Prostate

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...
The Lancet

Impact of adding hormone therapy to postoperative radiotherapy in prostate cancer

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...
Hosted on MSN

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Subscribe to our newsletter for the latest sci-tech ...
Reuters

Heavier men have lower PSA levels, study shows

NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...